How AdEPT Telecom plc Could Beat BT Group plc in 2016

AdEPT Telecom plc (LON: ADT) has the form to leave BT Group (LSE: BT.A) behind.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At today’s 468p share price BT Group (LSE: BT.A) is up almost 17% since January. Is that a trick the firm can repeat during 2016?

City analysts following the firm expect earnings to expand by 7% for the year to March 2017. That puts BT on a forward price-to-earnings (P/E) ratio of almost 15. And the forward dividend yield runs at 3.2% with those earnings covering the payout just over twice.

A successful rollout

The valuation looks about right to me, so there’s no obvious potential for the shares to re-rate upwards on valuation grounds. If BT’s shares are to perform well next year, we’ll need strong news flow regarding growth

Much hinges on the rollout programme for fibre broadband. Back in October BT said it continues to invest heavily to help the UK remain a broadband leader among major European nations. The figures are impressive. The firm’s open access network now passes 24 million premises in Britain and counting. Meanwhile, the directors reckon that demand for fibre is robust and five million homes and businesses are already connected.

So BT has obvious growth potential. But let’s not forget that the share price has already risen more than 520% since 2009. There’s a fair amount of cyclicality in BT’s business, which means the firm’s valuation has potential to contract as we move through the more mature phase of the current economic cycle. I wonder whether valuation-compression might hold back total returns for investors from here, even as growth continues. I’m cautious on BT now.

Impressive growth

I’m more attracted to FTSE AIM company AdEPT Telecom (ADT). The firm provides fixed line calls, line rental and broadband telecom services to commercial customers, ranging from small businesses to nationwide chains that have hundreds of branches. As well as organic growth, Adept pursues an acquisition programme with the aim of consolidating the telecom services industry. Growth has been robust and the shares are up 1325% since 2010, but there’s good reason to think that there’s more to come.

AdEPT won three framework contracts – for national and local governments, and for academic institutions. That happy situation now means that the firm is a nominated supplier and starting to win big contracts, such as the telecom services for whole councils. Meanwhile, a new £15m revolving credit facility has sufficient capacity left over after a recent acquisition to fund further purchases of earnings-enhancing businesses. The directors are relaxed about funding acquisitive growth with debt, citing the firm’s strong cash generation as justification.

At today’s 285p share price, AdEPT Telecom trades on a forward P/E rating around 15 for the year to March 2017 and there’s a forward dividend yield of 2.5%. City analysts following the firm expect forward earnings to cover the payout 2.6 times.

I think there’s a good chance that AdEPT Telecom could outperform BT during 2016. At the very least the firm is worthy of further research and inclusion on my watch list. One thing that I can’t deny is the blistering operational performance of the company so far.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »